Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 1 Constipation 1

Interventions

tegaserod 3 naloxegol 3 Radiotherapy 3 Cisplatin 3 Surveys and Questionnaires 2 Radiation 2 Lidocaine 2 prucalopride 1 pegfilgrastim 1 oxycodone naloxone combination 1 indole-3-carbinol 1 hydrated silica gel-based toothpaste 1 glucarpidase 1 angiotensin I (1-7) 1 alvimopan 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Vitamin D 1 Transcutaneous Electric Nerve Stimulation 1 Thyrotropin-Releasing Hormone 1 Tablets 1 Surgical Procedures, Operative 1 Sennosides 1 Selenomethionine 1 Phenolphthalein 1 Observation 1 Nutrition Assessment 1 Neck Dissection 1 Methotrexate 1 Methods 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × oxycodone naloxone combination × Other × Clear all

NCT01014559 2015-09-28

OXN3505

Mundipharma SAS

Phase 3 Terminated

Constipation, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡